Envestnet Asset Management Inc Organon & Co. Transaction History

Envestnet Asset Management Inc

$326 Billion
Q2 2025

A detailed history of Envestnet Asset Management Inc transactions in Organon & Co. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 34,228 shares of OGN stock, worth $321,058. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,228

Previous 303,138 88.71%

Holding current value

$321,058

Previous $4.51 Million 92.67%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 31, 2025	SELL	$8.04 - $14.72 $2.16 Million - $3.96 Million	-268,910 Reduced 88.71%	34,228 $331,000
Q1 2025 Apr 29, 2025	BUY	$14.29 - $16.41 $874,948 - $1 Million	61,228 Added 25.31%	303,138 $4.51 Million
Q4 2024 Feb 12, 2025	BUY	$14.44 - $18.83 $2.34 Million - $3.05 Million	162,188 Added 203.44%	241,910 $3.61 Million
Q3 2024 Nov 06, 2024	SELL	$18.65 - $23.03 $1.62 Million - $2.01 Million	-87,113 Reduced 52.22%	79,722 $1.53 Million
Q2 2024 Aug 08, 2024	BUY	$17.45 - $21.96 $170,224 - $214,219	9,755 Added 6.21%	166,835 $3.45 Million
Q1 2024 May 13, 2024	SELL	$13.78 - $18.8 $503,576 - $687,027	-36,544 Reduced 18.87%	157,080 $2.95 Million
Q4 2023 Feb 13, 2024	SELL	$10.95 - $17.32 $59,261 - $93,735	-5,412 Reduced 2.72%	193,624 $2.79 Million
Q3 2023 Nov 13, 2023	BUY	$16.59 - $23.77 $2.36 Million - $3.38 Million	142,301 Added 250.82%	199,036 $3.46 Million
Q2 2023 Aug 04, 2023	SELL	$19.27 - $24.63 $282,247 - $360,755	-14,647 Reduced 20.52%	56,735 $1.18 Million
Q1 2023 May 11, 2023	SELL	$21.42 - $32.08 $462,457 - $692,607	-21,590 Reduced 23.22%	71,382 $1.68 Million
Q4 2022 Feb 07, 2023	SELL	$23.31 - $28.61 $86,013 - $105,570	-3,690 Reduced 3.82%	92,972 $2.6 Million
Q3 2022 Nov 10, 2022	BUY	$23.4 - $34.25 $399,087 - $584,133	17,055 Added 21.42%	96,662 $2.26 Million
Q2 2022 Aug 03, 2022	BUY	$31.66 - $38.9 $572,507 - $703,428	18,083 Added 29.39%	79,607 $2.69 Million
Q1 2022 May 04, 2022	SELL	$30.45 - $39.36 $342,197 - $442,327	-11,238 Reduced 15.44%	61,524 $2.15 Million
Q4 2021 Feb 04, 2022	SELL	$28.67 - $37.13 $861,189 - $1.12 Million	-30,038 Reduced 29.22%	72,762 $2.22 Million
Q3 2021 Oct 07, 2021	SELL	$28.63 - $35.64 $1.33 Million - $1.66 Million	-46,627 Reduced 31.2%	102,800 $3.37 Million
Q2 2021 Aug 04, 2021	BUY	$28.45 - $38.0 $4.25 Million - $5.68 Million	149,427 New	149,427 $4.52 Million

Others Institutions Holding OGN

# of Institutions

792

Shares Held

210M

Call Options Held

2.74M

Put Options Held

1.79M

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $2.39B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Organon & Co. Transaction History